PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Oncimmune partners with Genentech to profile samples from rheumatology trials

Nottingham, UK-headquartered Oncimmune has signed a collaboration with Roche’s Genentech division to profile samples from the latter’s rheumatology clinical trials. ...
Continue Reading →
News

Keytruda/Lenvima combo shows promise in hard-to-treat cancers

MSD (Merck) and Eisai have revealed new data from two trials under the LEAP clinical programme evaluating the combination of MSD’s PD-1 inhibitor Keytruda and Eisai’...
Continue Reading →
News

GSK’s Zejula and AZ’s Lynparza leap toward broader EU approval

GlaxoSmithKline’s Zejula and AstraZeneca’s Lynparza have both moved towards EU approval in new indications after receiving positive opinions from the European Medici...
Continue Reading →
News

Roche acquires Irish biotech firm Inflazome

Swiss pharma company Roche is set to acquire Irish biotech firm Inflazome for an upfront payment of $449m (€380m). In addition to the upfront payment, Inflazome is...
Continue Reading →
News

Bristol Myers Squibb’s Opdivo shows benefit in oesophageal cancers

Bristol Myers Squibb’s Opdivo (nivolumab) demonstrated promise in a phase III CheckMate-577 trial involving patients with oesophageal or gastroesophageal junction (G...
Continue Reading →
News

2025 will see cell and gene therapy capacity shortages in the USA and 10+ mAb approvals in China

Continuous Bioprocessing growing quickly, but from a low base, with virtually all manufacturers now using at least some single use technologies Amsterdam, Septembe...
Continue Reading →
News

New laboratory and regulatory services for biotech customers

Gx Biological Solutions offers enhanced services for pharmaceutical primary packaging in the US and in EuropeUSA/Germany, September 21, 2020. Gerresheimer adds essen...
Continue Reading →
News

AZ pauses COVID-19 vaccine trials for safety review

AstraZeneca has paused late-stage clinical trials of AZD1222, an experimental COVID-19 vaccine being developed in partnership with the University of Oxford, after a ...
Continue Reading →
News

NICE turns down Celgene’s Revlimid as multiple myeloma maintenance treatment

The National Institute for Heath and Care Excellence (NICE) has turned down NHS funding of Celgene's Revlimid (lenalidomide) as maintenance treatment after an autolo...
Continue Reading →
News

NICE unites with global health leaders to highlight evidence-based healthcare

The UK’s National Institute for Health and Care Excellence (NICE) has joined a global initiative focused on bringing evidence-based healthcare to the fore worldwide....
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026